Hyloris And Hikma Get Maxigesic IV Approval In US

Launch Of Novel Paracetamol/Ibuprofen Solution For Infusion Is Expected In Early 2024

US flag thumbs up
The US FDA has approved Maxigesic IV • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin